Article
Effect of rosiglitazone on the differential expression of diabetes-associated proteins in pancreatic islets of C57Bl/6 lep/lep mice.
Molecular & cellular proteomics : MCP - 1 Jul 2002
Sanchez Jean-Charles, Converset Véronique, Nolan Anna, Schmid Gerhard, Wang Steven, Heller Manfred, Sennitt Matthew V, Hochstrasser Denis F, Cawthorne Michael A
Abstract excerpt
The insulin sensitizer drug, rosiglitazone, has been shown to have a protective effect on pancreatic islet cell structure and function in animal models of type 2 diabetes. The identification of new molecular targets associated both with islet cell dysfunction and protection is a crucial research goal. In the present study, a proteomics approach has been used to identify such targets. Obese C57Bl/6J lep/lep mice...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
